Full Press Release Details
MBX Biosciences Closes $115 Million Series B Financing to Advance Development of Endocrine Disease Programs.
MBX
MBX Biosciences Closes $115 Million Series B Financing to Advance Development of Endocrine Disease Programs
Key Takeaway: MBX Biosciences Closes $115 Million Series B Financing to Advance Development of Endocrine Disease Programs